Only a few days to go: We’re raising £25,000 to keep TheyWorkForYou running and make sure people across the UK can hold their elected representatives to account.

Donate to our crowdfunder

Clinical Priorities Advisory Group

Department of Health and Social Care written question – answered on 4th April 2018.

Alert me about debates like this

Photo of Mark Tami Mark Tami Opposition Pairing Whip (Commons)

To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 27 February to Question 128018, on Clinical Priorities Advisory Group, on what date NHS England plans to announce (a) announce the results of the prioritisation process and (b) make funding available for approved medicines policies.

Photo of Mark Tami Mark Tami Opposition Pairing Whip (Commons)

To ask the Secretary of State for Health and Social Care, what process was used to forecast budgetary need in order to determine the £25 million annual budget allocation for products undergoing review by the NHS England specialised commissioning prioritisation process.

Photo of Mark Tami Mark Tami Opposition Pairing Whip (Commons)

To ask the Secretary of State for Health and Social Care, what the (a) annual budget, (b) total annual expenditure and (c) rationale for how budget allocations were arrived at was for products reviewed by the NHS England specialised commissioning prioritisation process for the last three years for which figures are available.

Photo of Caroline Dinenage Caroline Dinenage Minister of State (Department of Health and Social Care)

NHS England has advised that it is expected that the recommendations from the relative prioritisation process will be received by the Specialised Services Commissioning Committee (SSCC) meeting on 19 June 2018. The aim will be to communicate the results as soon as possible following the SSCC meeting.

A process of relative prioritisation for determining discretionary investment in new specialised services was first introduced in 2016/17. Investment decisions are informed following advice from NHS England’s independently chaired Clinical Priorities Advisory Group and against a budget that is fixed annually. In 2016/17 and again in 2017/18, £25 million was set aside for this purpose. This was considered an appropriate level of investment in the context of NHS England’s Specialised Commissioning function having to achieve overall efficiency savings of approximately 2.7% and approximately 2.5% in 2016/17 and 2017/18 respectively in order to meet the financial pressures resulting from demographic growth and the legal requirement to fund all positive National Institute for Health and Care Excellence technology appraisals. Once funding is distributed following this relative prioritisation process, spend is not separately monitored.

Does this answer the above question?

Yes0 people think so

No0 people think not

Would you like to ask a question like this yourself? Use our Freedom of Information site.